Company Description
Sharecare, Inc. operates as a digital healthcare platform company.
Its Sharecare platform connects people, patients, providers, employers, health plans, government organizations, and communities that optimize individual and population-wide well-being.
The company offers enterprise solutions based on a software-as-a-service model that allows enterprise clients to message, motivate, and manage their populations, as well as measure their population progress; a suite of data and information-driven solutions; and life sciences solutions, which provides members with personalized information, programs, and resources to improve their health and well-being.
It also operates RealAge, a platform for health assessment to assess behaviors and existing conditions of its members and provide metric for their physical health.
In addition, the company provides secure, automated release of information, audit, and business consulting services to streamline the medical records process for medical facilities.
It sells its solutions through direct sales organization and partner relationships. Sharecare, Inc. was founded in 2009 and is headquartered in Atlanta, Georgia.
Country | United States |
Founded | 2009 |
Industry | Health Information Services |
Sector | Healthcare |
Employees | 3,352 |
CEO | Brent Layton |
Contact Details
Address: 255 East Paces Ferry Road NE, Suite 700 Atlanta, Georgia 30305 United States | |
Phone | 404 671 4000 |
Website | sharecare.com |
Stock Details
Ticker Symbol | SHCR |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001816233 |
CUSIP Number | 81948W104 |
ISIN Number | US81948W1045 |
Employer ID | 85-1365053 |
SIC Code | 8000 |
Key Executives
Name | Position |
---|---|
Brent Davis Layton | Chief Executive Officer and Director |
Jeffrey T. Arnold | Founder and Executive Chairman |
Dawn Whaley | President and Chief Marketing Officer |
Justin L. Ferrero | President and Chief Financial Officer |
Shannon Lee Bagley | Chief Operating Officer |
Michael Blalock | Chief Accounting Officer and Principal Accounting Officer |
Harsha Panyadahundi | Chief Technology Officer |
Walter De Brouwer | Chief Scientific Officer |
Colin Daniel | Chief Administrative Officer |
Henry Jay | General Counsel and Diversity Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Oct 23, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
Oct 22, 2024 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
Oct 22, 2024 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
Oct 22, 2024 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
Oct 22, 2024 | SC 13E3/A | [Amend] Going private transaction by certain issuers |
Oct 22, 2024 | 8-K | Current Report |
Oct 22, 2024 | 25-NSE | Filing |
Oct 17, 2024 | 8-K | Current Report |
Oct 7, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
Oct 7, 2024 | 8-K | Current Report |